1,5800 zł
0,00% 0,0000 zł
Milestone Medical Inc. (MMD)

Komunikaty spółki - MILESTONE

Validation and Implementation of Quick Start to the CompuFlo Epidural System
Closing of above market $4.7 million offering of common stock and warrants by Milestone Scientic Inc., the majority shareholder of the Issuer
Milestone Scientic, the Licensor of Milestone Medical Inc. Announces Pricing of Above Market $4.5 Million Public Offering of Common Stock and Warrants
Consolidated Annual Report for year ended December 31, 2019
The Impact of the COVID-19 Outbreak on Commercial Rollout of CompuFlo® Epidural System and Financial Results in 2020
The Update on The Partnership with RedOne Medical
Receiving CE Mark approval of pre-assembled disposable kit for CompuFlo® Epidural System in Europe
Receiving a Notice of Allowance for European Patent Related to Peripheral Nerve Block Instrument
Abstract acceptance of CompuFlo Epidural Instrument integrated with CompuWave for presentation at the Euroanaesthesia 2020 Congress
The receipt of five year follow-up report by expert and consultant in Peripheral Nerve Block (PNB) Regional Anesthesia; provides validation and confidence to advance CompuFlo in PNB market
Receiving a Notice of Allowance for U.S Patent related to Cosmetic Injection System
Receiving a Notice of Allowance on patent for CompuWave for integration into CompuFlo Epidural System
Dates for the Transmission of Periodical Reports in 2020
Reporting Ninth Published Study Reinforcing Efficacy of CompuFlo Epidural Instrument as an Objective Tool to Identify the Epidural Space and Reduce Risk of Accidental Dural Puncture
Milestone Medical Provides Year-End Update on Commercial Rollout of CompuFlo® Epidural System
Przejdź do strony za 5 Przejdź do strony »

Czy wiesz, że korzystasz z adblocka?
Reklamy nie są takie złe

To dzięki nim możemy udostępniać
Ci nasze treści.